Skip to main content
. 2017 Oct 26;144(1):18–27. doi: 10.1001/jamaoto.2017.1790

Table 2. Comparison of Long-term Outcomes by Groupa.

Outcome Measure All
(N = 64)
TORS Only
(n = 15)
TORS + RT
(n = 29)
TORS + CRT
(n = 20)
Effect Size, η2b Post Hoc Comparisons, Mean Difference (95% CI)
TORS Only vs TORS + RT TORS Only vs TORS + CRT TORS + RT vs TORS + CRT
Time postoperatively, mo 21 (12 to 36) 22.50 (12 to 36) 20 (13 to 36) 22 (14 to 33) .004 1.16 (−4.76 to 7.09) −0.01 (−6.35 to 6.34) −1.16 (−6.46 to 4.13)
Weight loss, mean (SD), lbc 19.70 (17.03) 7.92 (9.24) 24.02 (16.69) 22.50 (18.51) .153d −16.10 (−29.79 to −2.41)e −14.58 (−29.19 to .03) 1.52 (−11.01 to 14.04)
PSS–Normalcy of Diet 100 (10 to 100) 100 (60 to 100) 100 (50 to 100) 90 (10 to 100) .102 7.72 (−10.00 to 25.45) 18.00 (−1.30 to 37.03) 10.28 (−5.92 to 26.47)
PSS–Eating in Public 87.50 (0 to 100) 100 (75 to 100) 75 (50 to 100) 75 (0 to 100) .143f 9.66 (−6.58 to 25.89) 21.75 (4.32 to 39.18)d 12.09 (−2.74 to 26.93)
PSS–Speech Understandability 100 (25 to 100) 100 (75 to 100) 100 (50 to 100) 100 (25 to 100) .009 0.29 (−13.12 to 13.70) −0.83 (−15.24 to 13.57) −1.12 (−13.38 to 11.13)
EAT-10 7 (0 to 36) 4.50 (0 to 22) 9.50 (0 to 36) 9.50 (0 to 32) .080 −5.72 (−14.34 to 2.89) −8.05 (−17.30 to 1.20) −2.33 (−10.20 to 5.55)
HNQOL-Eating 83.33 (25 to 100) 89.59 (66.67 to 100) 83.33 (25 to 100) 68.34 (33.33 to 95.83) .165f 13.18 (−2.76 to 29.12) 21.15 (4.04 to 38.27)e 7.97 (−6.59 to 22.53)
HNQOL-Speech 93.75 (0 to 100) 100 (0 to 100) 93.75 (25 to 100) 84.38 (37.50 to 100) .017 −1.04 (−20.11 to 18.67) 0.72 (−21.86 to 19.78) 1.04 (−18.04 to 17.40)
HNQOL-Emotion 91.67 (33.33 to 100) 93.75 (66.67 to 100) 91.67 (37.50 to 100) 87.50 (33.33 to 100) .011 6.12 (−8.73 to 20.97) 6.81 (−9.14 to 22.76) 0.69 (−12.88 to 14.26)
HNQOL-Pain 87.50 (25 to 100) 90.63 (62.50 to 100) 90.63 (25 to 100) 84.38 (37.50 to 100) .023 3.69 (−12.16 to 19.55) 8.54 (−8.48 to 25.57) 4.85 (−9.64 to 19.34)

Abbreviations: CRT, chemoradiotherapy; EAT-10, 10-Item Eating Assessment Tool; HNQOL, Head and Neck Quality of Life; PSS, Performance Status Scale; RT, radiotherapy; TORS, transoral robotic surgery.

a

Data are presented as mean score (95% CI) unless otherwise indicated.

b

F tests for determining effect sizes for means.

c

To convert to kilograms, multiply by 0.45.

d

Significant difference using analysis of variance with α adjustment for multiple comparisons.

e

Significant between-group difference.

f

Significant difference using Kruskal-Wallis test with α adjustment for multiple comparisons.